Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Fentanyl
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[6] 46, 70, 97, 215, 231, 298 💬
2Fentanyl (High Dose)
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 215 💬
3Fentanyl (Low Dose)
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 215 💬
4Fentanyl (Low Dose) + Dexmedetomidine
(D10811)		[2] Dexmedetomidine,
Fentanyl		[5] Fentanyl ,
Dexmedetomidine ,
Dexmedetomidine hydrochloride ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[4] ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬 		[6] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215 💬
5Fentanyl B. Braun
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 97 💬
6Fentanyl transdermal patch
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 46 💬
7Intravenous midazolam (3 mg initially, with optional 3 mg boluses) plus fentanyl (100 mcg) for procedural sedation.
(D10811)		[2] Fentanyl,
Midazolam		[6] Fentanyl ,
Midazolam ,
Midazolam hydrochloride ,
Fentanyl citrate ,
Midazolam maleate ,
Fentanyl hydrochloride (D10811) 💬 		[17] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
OPRM1 💬 		[11] Cadherin signaling, Estrogen signaling pathway, GABAergic synapse, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 97 💬
8Intravenous remimazolam (5 mg initially, with optional 2.5 mg boluses) plus fentanyl (100 mcg) for procedural sedation.
(D10811)		[2] Fentanyl,
Remimazolam		[5] Fentanyl ,
Fentanyl citrate ,
Remimazolam besylate ,
Fentanyl hydrochloride (D10811),
Remimazolam 💬 		[17] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
OPRM1 💬 		[11] Cadherin signaling, Estrogen signaling pathway, GABAergic synapse, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 97 💬
9Multi-modal pain management [Fentanyl]
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 70 💬
10Standard analgesia use [Fentanyl]
(D10811)		[1] Fentanyl[3] Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 70 💬
11Transdermal fentanyl matrix, gabapentin
(D10811)		[2] Fentanyl,
Gabapentin		[4] Fentanyl ,
Gabapentin ,
Fentanyl citrate ,
Fentanyl hydrochloride (D10811) 💬 		[6] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
OPRM1,
SLC6A1 💬 		[14] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hormone signaling, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle 💬[1] 70 💬